Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The oncology research firm BeiGene has raised $97 million from private equity investors to sustain existing drug research programs. The company has three cancer drug candidates undergoing Phase I clinical trials and several other programs at the preclinical stage. Based in Beijing and employing 170 people, BeiGene is headed by the U.S. entrepreneur John V. Oyler, who previously launched the drug discovery services firm BioDuro in China.
This article has been sent to the following recipient: